Overview
Investment Type
Venture Capital
Mentions in press and media 4
| Date | Title | Description |
| Sign up to see | Sign up to see | Sign up to see |
| Sep 18, 2020 | Vedanta Biosciences taps Big Pharma vet Jeffrey Silber as CMO; Robert Doebele leaves behind teaching post at Colorado to focus on CSO job at Rain Therapeutics | Jeffrey Silber → A Big Pharma vet has joined Cambridge, MA upstart Vedanta Biosciences to help develop and expand on its microbiome-derived bacteria portfolio. Jeffrey Silber signed on as CMO of Vedanta after 4 years a... |
| Jun 8, 2020 | Microbiotica to collaborate with CRUK and CUH in landmark cancer microbiome study | CIC portfolio company Microbiotica to collaborate with Cancer Research UK and Cambridge University Hospitals in landmark cancer microbiome study Cambridge Innovation Capital (CIC), the venture capital investor enabling visionaries to build ... |
| Mar 27, 2019 | Cancer Research UK, Lifearc and Ono Pharma Form Cancer Immunotherapy Alliance | New immunotherapy drug targets for cancer will be progressed through a multimillion-pound drug discovery alliance announced today (Wednesday) between Cancer Research UK, LifeArc and Ono Pharmaceutical Co., Ltd. The multi-year partnership b... |
Reviews 0
FAQ about Cancer Research UK
What has the press written about Cancer Research UK?
Parsers VC has collected 4 articles mentioning Cancer Research UK, among them “Vedanta Biosciences taps Big Pharma vet Jeffrey Silber as CMO; Robert Doebele leaves behind teaching post at Colorado to focus on CSO job at Rain T...” (Sep 18, 2020) and “Microbiotica to collaborate with CRUK and CUH in landmark cancer microbiome study” (Jun 8, 2020).
Is Cancer Research UK still active?
Yes, Cancer Research UK is active; its latest activity on Parsers VC dates from Dec 22, 2021.